Detalhe da pesquisa
1.
Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Immunity
; 57(5): 1141-1159.e11, 2024 May 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38670113
2.
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
Proc Natl Acad Sci U S A
; 118(8)2021 02 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33593910
3.
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice.
Mol Ther
; 28(7): 1569-1584, 2020 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32359470
4.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075129
5.
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice.
Mol Ther Methods Clin Dev
; 22: 84-95, 2021 Sep 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34485597